Summit Therapeutics SMMT New Jersey And California — Total lease payments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.
The official record: Summit Therapeutics’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's new jersey and california — total lease payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's new jersey and california — total lease payments?
- Summit Therapeutics (SMMT) reported new jersey and california — total lease payments of $23.12M in Q4 2025.
- What does new jersey and california — total lease payments mean?
- The total cash paid for all lease obligations within the New Jersey and California region.
- How do you interpret new jersey and california — total lease payments?
- An increase suggests rising fixed operating costs or an expansion of leased facilities, whereas a decrease may signal cost-saving initiatives or a reduction in regional operational scale.
- How does new jersey and california — total lease payments compare across companies?
- Comparable to 'Total Lease Expense' or 'Operating Lease Cash Outflows' reported by other life sciences companies with significant R&D facilities in major US biotech hubs.